The process is driven by several linked changes rather than by arterial narrowing alone. As blood in the subarachnoid space breaks down, hemoglobin products and inflammation contribute to endothelial dysfunction, meaning impaired function of the vessel lining. These changes can interfere with arterial relaxation and sustain vascular smooth-muscle contraction, creating conditions for reduced cerebral blood flow.
The delayed timing reflects the period during which blood in the subarachnoid space breaks down and vascular effects develop. Hemoglobin products, inflammation, endothelial dysfunction, and sustained smooth-muscle contraction can progressively impair arterial relaxation. Consequently, a patient may develop reduced cerebral perfusion or new neurological deficits after the initial hemorrhagic event, creating a risk of secondary brain ischemia.
Narrowed intracranial arteries can restrict the amount of blood reaching brain tissue. If cerebral blood flow falls sufficiently, oxygen and nutrient delivery may become inadequate, producing secondary ischemia. This makes perfusion assessment clinically important: the severity of the vascular change matters because its consequences depend on whether the brain continues receiving enough blood to support normal neurological function.
Clinical teams monitor for new neurological deficits and signs of reduced cerebral perfusion. These findings can indicate that arterial narrowing is affecting brain function rather than remaining an isolated vascular change. Ongoing observation supports early detection, allowing clinicians to recognize possible secondary ischemia and reassess risk during the vulnerable period following subarachnoid hemorrhage.
Management may include nimodipine, careful hemodynamic management, and endovascular therapy. These approaches address the complication through medication, controlled support of circulation, or an intervention directed at the affected vessels. Treatment decisions occur in the context of neurological findings and cerebral perfusion, with the overall aim of limiting reduced blood flow and subsequent brain injury.
Delayed cerebral vasospasm adds a potentially preventable source of brain injury after hemorrhagic stroke. Recognizing its mechanisms and clinical warning signs helps teams perform risk assessment, monitor patients during the delayed period, and respond when perfusion or neurological status worsens. This clinical focus supports earlier intervention and may contribute to improved outcomes following subarachnoid hemorrhage.